# Safety of Heparin in Patients With Septic Shock

> **NCT01234285** · PHASE2 · WITHDRAWN · sponsor: **University of Colorado, Denver**

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** heparin
- **DRUG:** heparin
- **DRUG:** heparin
- **DRUG:** heparin

## Key facts

- **NCT ID:** NCT01234285
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-12
- **Primary completion:** 2013-04
- **Final completion:** 2013-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sara Cheng, MD has left the Univ. of Colorado and the study has been closed.
- **Last updated:** 2014-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01234285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01234285, "Safety of Heparin in Patients With Septic Shock". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01234285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*